Maria Delivoria-Papadopoulos Selected Research

Brain Hypoxia (Cerebral Hypoxia)

1/2022	Computational analysis of cortical neuronal excitotoxicity in a large animal model of neonatal brain injury.
8/2017	Effects of Src kinase inhibition on expression of pro-caspase-2 after brain hypoxia in a piglet animal model.
1/2017	Effects of Src Kinase Inhibition on Expression of Protein Tyrosine Phosphatase 1B after Brain Hypoxia in a Piglet Animal Model.
11/2015	Temporal Changes in Caspase-1 and Caspase-8 Activities Following Brain Hypoxia With and Without Src kinase Inhibition in a Piglet Animal Model.
8/2010	Mechanism of tyrosine phosphorylation of procaspase-9 and Apaf-1 in cytosolic fractions of the cerebral cortex of newborn piglets during hypoxia.
6/2008	Effect of hypoxia on the expression of procaspase-9 and procaspase-3 in neuronal nuclear, mitochondrial and cytosolic fractions of the cerebral cortex of newborn piglets.
12/2007	ATP and cytochrome c-dependent activation of caspase-9 during hypoxia in the cerebral cortex of newborn piglets.
7/2007	Differential expression of apoptotic proteins following hypoxia-induced CREB phosphorylation in the cerebral cortex of newborn piglets.
3/2007	Mechanisms of expression of apoptotic protease activating factor-1 (Apaf-1) in nuclear, mitochondrial and cytosolic fractions of the cerebral cortex of newborn piglets.
3/2007	Mechanism of activation of caspase-9 and caspase-3 during hypoxia in the cerebral cortex of newborn piglets: the role of nuclear Ca2+ -influx.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Maria Delivoria-Papadopoulos Research Topics

Disease

60	Hypoxia (Hypoxemia) 01/2022 - 01/2002
20	Brain Hypoxia (Cerebral Hypoxia) 01/2022 - 01/2002
3	Hyperoxia 07/2010 - 07/2007
3	Hypocapnia 01/2007 - 12/2003
2	Ischemia 01/2018 - 02/2006
2	Neuroblastoma 05/2017 - 12/2014
2	Neoplasms (Cancer) 05/2017 - 12/2014
1	Developmental Disabilities (Developmental Disability) 01/2022
1	Brain Injuries (Brain Injury) 01/2022
1	Sarcoma (Soft Tissue Sarcoma) 01/2022
1	Brain Edema (Cerebral Edema) 01/2018
1	Hypothermia 01/2018
1	Brain Hypoxia-Ischemia (Hypoxia Ischemia, Brain) 11/2017
1	Inflammation (Inflammations) 11/2015
1	Neoplasm Metastasis (Metastasis) 12/2014
1	Asphyxia (Suffocation) 08/2007
1	Seizures (Absence Seizure) 10/2006

Drug/Important Bio-Agent (IBA)

36	Adenosine Triphosphate (ATP)IBA 01/2018 - 01/2002
33	Proteins (Proteins, Gene)FDA Link 01/2018 - 01/2002
30	Phosphocreatine (Neoton)IBA 08/2012 - 01/2002
18	Nitric Oxide (Nitrogen Monoxide)FDA Link 09/2010 - 01/2002
13	Caspase 9IBA 08/2012 - 07/2004
11	src-Family KinasesIBA 01/2022 - 08/2009
11	Calcium-Calmodulin-Dependent Protein Kinase Type 4IBA 01/2018 - 04/2002
11	Tyrosine (L-Tyrosine)FDA Link 08/2011 - 01/2004
9	Phosphotransferases (Kinase)IBA 08/2017 - 04/2002
9	Caspase 3 (Caspase-3)IBA 08/2012 - 09/2002
9	Adenosine Triphosphatases (ATPase)IBA 08/2008 - 03/2004
9	Free RadicalsIBA 07/2008 - 01/2002
8	CaspasesIBA 08/2017 - 09/2002
8	Cyclic AMP Response Element-Binding Protein (Cyclic AMP-Responsive DNA-Binding Protein)IBA 08/2011 - 02/2005
8	Apoptosis Regulatory ProteinsIBA 07/2010 - 12/2003
8	DNA (Deoxyribonucleic Acid)IBA 07/2008 - 11/2002
7	Calmodulin (Calcium-Dependent Activator Protein)IBA 01/2022 - 04/2002
6	Clonidine (ST 155)FDA LinkGeneric 01/2010 - 03/2007
6	7-nitroindazoleIBA 12/2006 - 11/2004
5	Calcium-Calmodulin-Dependent Protein KinasesIBA 01/2018 - 12/2002
5	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 09/2010 - 06/2006
5	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 08/2007 - 01/2002
5	SodiumIBA 12/2006 - 11/2004
4	Oxygen (Dioxygen)IBA 01/2018 - 01/2002
4	Protein Tyrosine PhosphatasesIBA 08/2009 - 05/2004
4	SaltsIBA 12/2006 - 11/2004
4	Nitric Oxide Synthase (NO Synthase)IBA 11/2004 - 01/2002
3	Cytochromes c (Cytochrome c)IBA 11/2017 - 07/2004
3	EnzymesIBA 08/2011 - 07/2004
3	Phosphates (Orthophosphate)IBA 03/2011 - 07/2004
3	Peptide Hydrolases (Proteases)FDA Link 08/2010 - 03/2007
3	phosphocreatinineIBA 01/2010 - 06/2006
3	CalciumIBA 10/2006 - 04/2002
3	bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA 07/2006 - 01/2002
3	Magnesium Sulfate (Sulfate, Magnesium)FDA LinkGeneric 01/2006 - 09/2005
3	N-Methylaspartate (NMDA)IBA 01/2004 - 01/2002
2	ErbB Receptors (EGF Receptor)IBA 12/2020 - 09/2010
2	PaxillinIBA 05/2017 - 12/2014
2	Serine (L-Serine)FDA Link 07/2009 - 01/2004
2	NG-Nitroarginine Methyl Ester (L-NAME)IBA 07/2008 - 02/2008
2	6-pyruvoyltetrahydropterin synthase (PTPS)IBA 02/2008 - 05/2004
2	Membrane LipidsIBA 01/2007 - 02/2002
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2006 - 11/2004
2	EndonucleasesIBA 02/2004 - 05/2003
2	triphosphoric acid (triphosphate)IBA 02/2004 - 10/2003
2	Inositol (Myoinositol)IBA 02/2004 - 10/2003
2	Arginine (L-Arginine)FDA Link 12/2002 - 11/2002
2	Ion Channels (Ion Channel)IBA 02/2002 - 01/2002
2	Glutamic Acid (Glutamate)FDA Link 02/2002 - 01/2002
1	Pharmaceutical PreparationsIBA 01/2022
1	antineoplaston A10 (A 10)IBA 01/2018
1	Apoptosis Inducing FactorIBA 11/2017
1	Caspase 2IBA 08/2017
1	Non-Receptor Type 1 Protein Tyrosine PhosphataseIBA 01/2017
1	Biomarkers (Surrogate Marker)IBA 11/2015
1	tyrosine receptor (receptor, tyrosine)IBA 11/2015
1	Caspase 8 (Caspase-8)IBA 11/2015
1	Focal Adhesion Protein-Tyrosine KinasesIBA 12/2014
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 11/2014
1	ImidazolinesIBA 08/2008
1	p38 Mitogen-Activated Protein KinasesIBA 07/2008
1	arginine methyl esterIBA 07/2008
1	Mitogen-Activated Protein KinasesIBA 07/2008
1	JNK Mitogen-Activated Protein KinasesIBA 07/2008
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 07/2008
1	bcl-Associated Death ProteinIBA 07/2008
1	caspase-activated deoxyribonucleaseIBA 07/2008
1	Fibrinogen (Factor I)FDA Link 12/2007
1	benzyloxycarbonyl- leucyl- glutamyl- histidyl- aspartic acid fluoromethyl ketoneIBA 06/2007
1	Adenosine Monophosphate (AMP)IBA 05/2007
1	Apoptosomes (Apoptosome)IBA 03/2007
1	Calcium-Transporting ATPases (Ca2+ ATPase)IBA 03/2007
1	Kainic Acid (Kainate)IBA 10/2006
1	Inosine FDA Link 02/2006
1	Purine NucleosidesIBA 02/2006
1	Adenosine (Adenocard)FDA LinkGeneric 02/2006
1	Xanthine OxidaseIBA 02/2006
1	Neurotransmitter Agents (Neurotransmitter)IBA 02/2006
1	PurinesIBA 02/2006
1	Allopurinol (Remid)FDA LinkGeneric 02/2006
1	purineIBA 02/2006

Therapy/Procedure

1	Therapeutics 01/2018
1	Resuscitation 08/2007